Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection insights, today announced it will be presenting new data ...

The hope is using AI to judge outcomes will ease the high cost and complexity of running big clinical trials, say researchers.

We show that, compared with surgeon predictions and existing risk-prediction tools, our machine-learning model can enhance ...